Changchun Baike Biotech Co., Ltd. 2022 Restricted Stock Incentive Plan granted part of the first vesting period results and share listing announcement
Announcement of Changchun Baike Biotechnology Co., Ltd. on the acceptance of the application for voluntary disclosure of the marketing license for the live attenuated nasal spray influenza vaccine
Baike Biotech Investor Relations Activity Record Form (20240423)
Changchun Baike Biotechnology Co., Ltd. report for the first quarter of 2024
Announcement of Changchun Baike Biotechnology Co., Ltd. on the progress of foreign investment
Announcement of Changchun Baike Biotechnology Co., Ltd. on holding a performance briefing for the first quarter of 2024
Announcement of Resolutions of the 2023 Annual General Meeting of Shareholders of Changchun Baike Biotechnology Co., Ltd.
Legal Opinion of Beijing Zhide Law Firm on the 2023 Annual General Meeting of Shareholders of Changchun Baike Biotechnology Co., Ltd.
Voluntary Disclosure Notice of Changchun Baike Biotechnology Co., Ltd. Results Forecast for the First Quarter of 2024
CITIC Securities Co., Ltd. site inspection report on Changchun Baike Biotech Co., Ltd.'s 2023 continuous supervision work site
Changchun Baike Biotechnology Co., Ltd. 2023 Annual General Meeting Meeting Information
CITIC Securities Co., Ltd.'s 2023 Continuous Supervision and Follow-up Report on Changchun Baike Biotech Co., Ltd.
Baike Biotech Investor Relations Activity Record Form(20240322)
Changchun Baike Biotechnology Co., Ltd. 2023 Internal Control Audit Report
Report on the performance of the Audit Committee of the Board of Directors of Changchun Baike Biotechnology Co., Ltd. in 2023
Special Audit Report of Changchun Baike Biotechnology Co., Ltd. 2023 Summary of Non-operating Capital Occupation and Other Related Capital Transactions
Changchun Baike Biotechnology Co., Ltd.'s special report on the self-inspection of the independence of independent directors
Changchun Baike Biotechnology Co., Ltd.'s evaluation report on the performance of accounting firms
2023 Independent Director Debriefing Report of Changchun Baike Biotechnology Co., Ltd. (Pay 100 years)
2023 Independent Director Debriefing Report of Changchun Baike Biotechnology Co., Ltd. (Xu Dayong)
No Data